You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

single subject

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rumination, Depressive Symptoms, Blood Pressure Trial (Rumination-Focused Cognitive Behavior Therapy)

Not yet recruiting
  • Rumination
  • +2 more
  • Rumination-Focused Cognitive Behavior Therapy
  • (no location specified)
Aug 4, 2023

Frontotemporal Dementia Trial (LAM-002A)

No longer available
  • Frontotemporal Dementia
  • (no location specified)
Jul 29, 2022

Polycystic Kidney Trial in Rochester (Lixivaptan)

No longer available
  • Polycystic Kidney
  • Rochester, Minnesota
    Mayo Clinic
Oct 8, 2021

Diabetes Trial (HR011408 injection; NovoRapid®, NovoRapid®;HR011408 injection)

Not yet recruiting
  • Diabetes
  • HR011408 injection; NovoRapid®
  • NovoRapid®；HR011408 injection
  • (no location specified)
Feb 12, 2023

Healthy Trial in Hangzhou (LPM3480392, Placebo)

Completed
  • Healthy
  • Hangzhou, Zhejiang, China
    The second affiliated hosipital zhejiang university school of me
May 15, 2023

Leber Hereditary Optic Neuropathy (Optic, Atrophy, Hereditary, Leber) Trial (GS010)

Available
  • Leber Hereditary Optic Neuropathy (Optic, Atrophy, Hereditary, Leber)
  • GS010
  • (no location specified)
Aug 2, 2021

MDS, Acute Myeloid Leukemia With Myelodysplasia Related Disease and < 30% Blasts, Mixed Myelodysplastic/Myeloproliferative

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Stockholm, Sweden
    Department of Hematology, Karolinska University Hospital
Mar 27, 2023

Healthy Trial in Qingdao (Test Empagliflozin And Linagliptin Tablets, Reference Empagliflozin And Linagliptin tablets)

Completed
  • Healthy
  • Test Empagliflozin And Linagliptin Tablets
  • Reference Empagliflozin And Linagliptin tablets
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University Phase I Clinical R
Jul 14, 2023

Neuropathic Pain Trial in Lexington (onabotulinum toxin A)

Recruiting
  • Neuropathic Pain
  • onabotulinum toxin A
  • Lexington, Kentucky
    Orofacial Pain Center
Dec 9, 2021

Crow's Feet Trial in Seoul (DKB-119)

Active, not recruiting
  • Crow's Feet
  • DKB-119
  • Seoul, Korea, Republic of
    Chungang-University Hospital
Aug 28, 2023

Healthy Subject Trial in Seoul (Neomazine Tab. 100mg, Myungin Chlorpromazine HCl Tab. 100mg)

Completed
  • Healthy Subject
  • Neomazine Tab. 100mg
  • Myungin Chlorpromazine HCl Tab. 100mg
  • Seoul, Korea, Republic of
    Whan In Pharm.
Nov 23, 2023

Lip Abnormality Trial in Vienna (Thioderm Elate, Juvéderm Ultra 3)

Active, not recruiting
  • Lip Abnormality
  • Thioderm Elate
  • Juvéderm Ultra 3
  • Vienna, Austria
    H&P Ambulatorien GmbH
Nov 14, 2023

Healthy Volunteer Trial in Cypress (MT1013)

Completed
  • Healthy Volunteer
  • Cypress, California
    WCCT Global, Inc.
Jul 28, 2022

Mid Face Volume Deficit Trial in Vienna (Thioderm Strong, Juvéderm VOLUMA Lidocaine)

Active, not recruiting
  • Mid Face Volume Deficit
  • Thioderm Strong
  • Juvéderm VOLUMA Lidocaine
  • Vienna, Austria
    H&P Ambulatorien GmbH
Nov 9, 2023

Cognitive Disorders Trial (Blood samples, Interviewing the subject and scales, Neurocognitive evaluation)

Not yet recruiting
  • Cognitive Disorders
  • Blood samples
  • +5 more
  • (no location specified)
May 25, 2023

Diabetes in Adults Trial (HR011408 injection)

Not yet recruiting
  • Diabetes in Adults
  • HR011408 injection
  • (no location specified)
Nov 24, 2021

Healthy Subject Trial in Xingtai (STSA-1002 Injection, STSA-1005 Injection)

Recruiting
  • Healthy Subject
  • STSA-1002 Injection
  • STSA-1005 Injection
  • Xingtai, Hebei, China
    The Second Affiliated Hospital Of Xingtai Medical College
Nov 22, 2022

Healthy Subject Trial in Seongnam, Daejeon (CT-P41, US-licensed Prolia)

Completed
  • Healthy Subject
  • CT-P41
  • US-licensed Prolia
  • Seongnam, Bundang-gu, Korea, Republic of
  • +1 more
Sep 7, 2023

Healthy Subject Trial in Chengdu (GS3-007 oral liquid)

Not yet recruiting
  • Healthy Subject
  • GS3-007 oral liquid
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Jun 16, 2023

Healthy Trial in Miami (Lu AG06474, Placebo)

Completed
  • Healthy
  • Lu AG06474
  • Placebo
  • Miami, Florida
    Quotient Sciences Miami
Jan 5, 2023

Healthy Subject Trial in Chengdu (GS3-007 oral liquid or Placebo GS3-007 oral liquid oral medication)

Recruiting
  • Healthy Subject
  • GS3-007 oral liquid or Placebo GS3-007 oral liquid oral medication
  • Chengdu, Chengdu, China
    Chengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Nov 7, 2022

Hepatic Impairment Trial in China (Orelabrutinib Tablets)

Not yet recruiting
  • Hepatic Impairment
  • Orelabrutinib Tablets
  • Bengbu, Anhui, China
  • +4 more
Jan 12, 2023

Gout Trial in Perth (XNW3009, Placebo)

Completed
  • Gout
  • Perth, West Austrialia, Australia
    Linear Clinical Research
Jan 4, 2022

Subjects With Liver Function Injury, Normal Liver Function Subject Trial in Changchun (Deuremidevir Hydrobromide Tablets)

Completed
  • Subjects With Liver Function Injury
  • Normal Liver Function Subject
  • Deuremidevir Hydrobromide Tablets
  • Changchun, Jilin, China
    The First Hospital of Jilin University Ethics Committee
Oct 16, 2023

Pharmacokinetics, Safety, Efficacy Trial in Dhaka (Advixa (Adalimumab))

Recruiting
  • Pharmacokinetics
  • +3 more
  • Advixa (Adalimumab)
  • Dhaka, Bangladesh
    ideSHi
Jul 6, 2022